Eileen Chang
Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fetus | 14 | 2022 | 699 | 1.940 |
Why?
| Ketamine | 5 | 2018 | 104 | 1.640 |
Why?
| Placental Insufficiency | 4 | 2021 | 104 | 1.540 |
Why?
| Fetal Hypoxia | 6 | 2018 | 48 | 1.540 |
Why?
| Fetal Growth Retardation | 5 | 2021 | 473 | 1.380 |
Why?
| Sheep | 19 | 2022 | 769 | 1.260 |
Why?
| Muscle, Skeletal | 6 | 2022 | 1556 | 0.990 |
Why?
| Muscle Development | 2 | 2021 | 106 | 0.890 |
Why?
| Myoblasts, Skeletal | 1 | 2021 | 11 | 0.840 |
Why?
| Fetal Development | 2 | 2021 | 263 | 0.830 |
Why?
| Muscle Fibers, Skeletal | 2 | 2021 | 197 | 0.790 |
Why?
| Amino Acids | 3 | 2022 | 463 | 0.760 |
Why?
| Insulin-Like Growth Factor I | 4 | 2021 | 288 | 0.640 |
Why?
| Insulin | 3 | 2021 | 2180 | 0.580 |
Why?
| Excitatory Amino Acid Antagonists | 2 | 2018 | 91 | 0.580 |
Why?
| Hypoxia, Brain | 1 | 2016 | 8 | 0.570 |
Why?
| Cerebral Cortex | 2 | 2018 | 430 | 0.560 |
Why?
| Lower Extremity | 1 | 2019 | 345 | 0.540 |
Why?
| Pregnancy | 14 | 2022 | 5854 | 0.530 |
Why?
| Adrenocorticotropic Hormone | 2 | 2016 | 153 | 0.530 |
Why?
| Neuroprotective Agents | 1 | 2016 | 110 | 0.520 |
Why?
| Anesthetics, Dissociative | 1 | 2015 | 31 | 0.520 |
Why?
| Hypoglycemic Agents | 1 | 2021 | 1055 | 0.480 |
Why?
| Hypoxia | 5 | 2020 | 1003 | 0.470 |
Why?
| Hydrocortisone | 2 | 2016 | 315 | 0.470 |
Why?
| Inflammation Mediators | 1 | 2016 | 515 | 0.440 |
Why?
| Anti-Inflammatory Agents | 1 | 2016 | 469 | 0.430 |
Why?
| Animals | 26 | 2022 | 34133 | 0.370 |
Why?
| Hypothalamus | 3 | 2016 | 155 | 0.350 |
Why?
| Kidney | 1 | 2015 | 1355 | 0.320 |
Why?
| Pregnancy, Animal | 2 | 2019 | 58 | 0.320 |
Why?
| Umbilical Cord | 2 | 2018 | 82 | 0.300 |
Why?
| Gestational Age | 4 | 2021 | 787 | 0.290 |
Why?
| Matrix Metalloproteinases | 3 | 2010 | 91 | 0.260 |
Why?
| Female | 21 | 2022 | 63629 | 0.240 |
Why?
| Islets of Langerhans | 2 | 2021 | 749 | 0.230 |
Why?
| Ventricular Remodeling | 3 | 2010 | 230 | 0.230 |
Why?
| Drug Administration Schedule | 2 | 2021 | 757 | 0.220 |
Why?
| Fetal Blood | 3 | 2021 | 275 | 0.220 |
Why?
| Transcriptome | 3 | 2018 | 774 | 0.210 |
Why?
| Citrate (si)-Synthase | 1 | 2021 | 48 | 0.210 |
Why?
| Muscle Proteins | 2 | 2022 | 218 | 0.210 |
Why?
| Placenta | 4 | 2021 | 648 | 0.200 |
Why?
| Infusions, Intravenous | 1 | 2021 | 396 | 0.190 |
Why?
| Bromodeoxyuridine | 1 | 2019 | 78 | 0.180 |
Why?
| Alanine | 1 | 2019 | 103 | 0.170 |
Why?
| Hindlimb | 1 | 2019 | 138 | 0.170 |
Why?
| Sheep, Domestic | 2 | 2016 | 32 | 0.170 |
Why?
| Coronary Vessels | 1 | 2020 | 237 | 0.160 |
Why?
| Drug Resistance, Multiple, Bacterial | 1 | 2017 | 66 | 0.150 |
Why?
| Staphylococcus | 1 | 2017 | 72 | 0.150 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2016 | 783 | 0.150 |
Why?
| Temperature | 1 | 2019 | 631 | 0.150 |
Why?
| Ventricular Function, Left | 2 | 2010 | 493 | 0.150 |
Why?
| Selection, Genetic | 2 | 2012 | 254 | 0.140 |
Why?
| Triclosan | 1 | 2016 | 9 | 0.140 |
Why?
| Endocrine Disruptors | 1 | 2016 | 34 | 0.140 |
Why?
| Gene Expression Profiling | 4 | 2016 | 1625 | 0.140 |
Why?
| Myocytes, Cardiac | 1 | 2020 | 483 | 0.140 |
Why?
| Mitochondria | 1 | 2021 | 809 | 0.140 |
Why?
| Systems Biology | 1 | 2016 | 59 | 0.140 |
Why?
| Glucose | 1 | 2021 | 968 | 0.140 |
Why?
| Anti-Infective Agents, Local | 1 | 2016 | 56 | 0.140 |
Why?
| Pituitary Gland | 1 | 2016 | 164 | 0.130 |
Why?
| Oxidative Stress | 1 | 2021 | 1204 | 0.130 |
Why?
| Ischemia | 1 | 2018 | 382 | 0.130 |
Why?
| Analgesics | 1 | 2016 | 163 | 0.130 |
Why?
| Receptors, N-Methyl-D-Aspartate | 1 | 2016 | 192 | 0.130 |
Why?
| Brachiocephalic Trunk | 1 | 2014 | 11 | 0.130 |
Why?
| Chemokines | 1 | 2015 | 233 | 0.120 |
Why?
| Saccharomyces cerevisiae | 2 | 2012 | 507 | 0.120 |
Why?
| Disease Models, Animal | 5 | 2016 | 3799 | 0.120 |
Why?
| Interleukins | 1 | 2015 | 246 | 0.120 |
Why?
| RNA, Messenger | 3 | 2016 | 2720 | 0.120 |
Why?
| Endocrine System | 1 | 2013 | 23 | 0.110 |
Why?
| Blood Pressure | 3 | 2016 | 1713 | 0.110 |
Why?
| Myosin Light Chains | 1 | 2012 | 35 | 0.110 |
Why?
| Two-Hybrid System Techniques | 1 | 2012 | 58 | 0.110 |
Why?
| Cardiac Myosins | 1 | 2012 | 33 | 0.110 |
Why?
| Molecular Biology | 1 | 2012 | 58 | 0.110 |
Why?
| Immune System | 1 | 2013 | 184 | 0.100 |
Why?
| Hemodynamics | 1 | 2016 | 1036 | 0.100 |
Why?
| Cardiomegaly | 1 | 2012 | 168 | 0.100 |
Why?
| Transcription Factors | 2 | 2014 | 1616 | 0.100 |
Why?
| Myocardial Contraction | 1 | 2012 | 339 | 0.100 |
Why?
| Estradiol | 1 | 2014 | 477 | 0.100 |
Why?
| Gene Expression | 1 | 2016 | 1506 | 0.100 |
Why?
| Homeodomain Proteins | 1 | 2014 | 484 | 0.090 |
Why?
| Apoptosis | 1 | 2019 | 2532 | 0.090 |
Why?
| Heart Conduction System | 1 | 2010 | 88 | 0.090 |
Why?
| Electric Stimulation Therapy | 1 | 2010 | 75 | 0.090 |
Why?
| Stress, Physiological | 1 | 2012 | 433 | 0.090 |
Why?
| Adaptation, Physiological | 1 | 2012 | 510 | 0.080 |
Why?
| Fibroblasts | 2 | 2010 | 846 | 0.080 |
Why?
| Basigin | 1 | 2008 | 27 | 0.080 |
Why?
| Gene Expression Regulation | 2 | 2016 | 2491 | 0.080 |
Why?
| Aortic Aneurysm, Thoracic | 1 | 2010 | 124 | 0.080 |
Why?
| Up-Regulation | 4 | 2014 | 891 | 0.080 |
Why?
| Genomics | 1 | 2013 | 714 | 0.080 |
Why?
| Brain | 2 | 2017 | 2540 | 0.080 |
Why?
| Aorta, Thoracic | 1 | 2010 | 252 | 0.080 |
Why?
| Arrhythmias, Cardiac | 1 | 2010 | 310 | 0.080 |
Why?
| Heart Defects, Congenital | 1 | 2014 | 721 | 0.080 |
Why?
| Time Factors | 2 | 2016 | 6682 | 0.070 |
Why?
| Saccharomyces cerevisiae Proteins | 2 | 2012 | 354 | 0.070 |
Why?
| Oxygen | 2 | 2021 | 887 | 0.070 |
Why?
| Inflammation | 1 | 2015 | 2598 | 0.060 |
Why?
| Ventricular Dysfunction, Left | 1 | 2008 | 401 | 0.060 |
Why?
| Carcinoma, Squamous Cell | 1 | 2010 | 622 | 0.060 |
Why?
| Genetic Complementation Test | 1 | 2003 | 62 | 0.060 |
Why?
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 346 | 0.060 |
Why?
| Adenocarcinoma | 1 | 2010 | 837 | 0.060 |
Why?
| Energy Metabolism | 2 | 2021 | 783 | 0.060 |
Why?
| Myocardium | 1 | 2008 | 982 | 0.060 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2018 | 852 | 0.050 |
Why?
| Myocardial Infarction | 1 | 2010 | 1134 | 0.050 |
Why?
| Mice, Transgenic | 3 | 2014 | 2079 | 0.050 |
Why?
| Leucine | 1 | 2022 | 117 | 0.050 |
Why?
| Male | 9 | 2021 | 59639 | 0.050 |
Why?
| Ventricular Pressure | 2 | 2012 | 42 | 0.050 |
Why?
| Infusion Pumps | 1 | 2021 | 31 | 0.050 |
Why?
| Placental Circulation | 1 | 2021 | 57 | 0.050 |
Why?
| Oxidative Phosphorylation | 1 | 2021 | 160 | 0.050 |
Why?
| Down-Regulation | 2 | 2014 | 654 | 0.050 |
Why?
| Placentation | 1 | 2021 | 44 | 0.050 |
Why?
| Fetal Macrosomia | 1 | 2021 | 57 | 0.050 |
Why?
| Pancreatic Diseases | 1 | 2021 | 68 | 0.050 |
Why?
| Fetal Weight | 1 | 2021 | 51 | 0.050 |
Why?
| Fetal Diseases | 1 | 2021 | 149 | 0.050 |
Why?
| Organ Size | 1 | 2021 | 474 | 0.050 |
Why?
| Matrix Metalloproteinase 2 | 2 | 2010 | 57 | 0.040 |
Why?
| Heart Failure | 1 | 2012 | 2114 | 0.040 |
Why?
| Insulin-Like Growth Factor II | 1 | 2018 | 24 | 0.040 |
Why?
| Mice, Inbred C57BL | 3 | 2014 | 5020 | 0.040 |
Why?
| Aging | 1 | 2008 | 1694 | 0.040 |
Why?
| Swine | 2 | 2010 | 777 | 0.040 |
Why?
| Lung Neoplasms | 1 | 2010 | 2216 | 0.040 |
Why?
| Heart Ventricles | 2 | 2014 | 741 | 0.040 |
Why?
| Diabetes, Gestational | 1 | 2021 | 285 | 0.040 |
Why?
| DNA, Bacterial | 1 | 2018 | 324 | 0.040 |
Why?
| Arteries | 1 | 2018 | 256 | 0.040 |
Why?
| Echocardiography | 2 | 2010 | 591 | 0.040 |
Why?
| Stroke Volume | 2 | 2010 | 553 | 0.040 |
Why?
| Heart Rate | 2 | 2010 | 756 | 0.040 |
Why?
| Microglia | 1 | 2017 | 214 | 0.030 |
Why?
| Maternal-Fetal Exchange | 1 | 2016 | 157 | 0.030 |
Why?
| Homeobox Protein Nkx-2.5 | 1 | 2014 | 3 | 0.030 |
Why?
| Mice | 4 | 2014 | 15888 | 0.030 |
Why?
| Carbon Dioxide | 1 | 2016 | 237 | 0.030 |
Why?
| Reproduction | 1 | 2016 | 195 | 0.030 |
Why?
| Gene Knock-In Techniques | 1 | 2014 | 48 | 0.030 |
Why?
| Gene Regulatory Networks | 1 | 2016 | 244 | 0.030 |
Why?
| Disease Progression | 2 | 2012 | 2546 | 0.030 |
Why?
| Neuropeptides | 1 | 2014 | 70 | 0.030 |
Why?
| Phenotype | 2 | 2014 | 3070 | 0.030 |
Why?
| Reproducibility of Results | 2 | 2013 | 2977 | 0.030 |
Why?
| Heterozygote | 1 | 2014 | 270 | 0.030 |
Why?
| Gene Ontology | 1 | 2013 | 57 | 0.030 |
Why?
| Cell Cycle | 1 | 2016 | 584 | 0.030 |
Why?
| Myosin-Light-Chain Kinase | 1 | 2012 | 26 | 0.030 |
Why?
| Models, Genetic | 1 | 2016 | 599 | 0.030 |
Why?
| Pulmonary Ventilation | 1 | 2013 | 72 | 0.030 |
Why?
| Mice, 129 Strain | 1 | 2012 | 80 | 0.030 |
Why?
| Ubiquitin | 1 | 2012 | 68 | 0.030 |
Why?
| Mutation, Missense | 1 | 2014 | 302 | 0.030 |
Why?
| Lymphocytes | 1 | 2014 | 360 | 0.030 |
Why?
| Culture Media | 1 | 2012 | 165 | 0.030 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2012 | 140 | 0.030 |
Why?
| Protein Structure, Tertiary | 1 | 2014 | 832 | 0.030 |
Why?
| Receptors, Estrogen | 1 | 2014 | 388 | 0.030 |
Why?
| Brain Ischemia | 1 | 2014 | 311 | 0.020 |
Why?
| Calcium Chloride | 1 | 2010 | 15 | 0.020 |
Why?
| Feeding Behavior | 1 | 2016 | 627 | 0.020 |
Why?
| Macrophages | 1 | 2017 | 1334 | 0.020 |
Why?
| Aorta | 1 | 2012 | 368 | 0.020 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 2010 | 162 | 0.020 |
Why?
| Diastole | 1 | 2010 | 147 | 0.020 |
Why?
| Amino Acid Sequence | 1 | 2014 | 2123 | 0.020 |
Why?
| Thoracotomy | 1 | 2010 | 86 | 0.020 |
Why?
| Systole | 1 | 2010 | 178 | 0.020 |
Why?
| Epigenesis, Genetic | 1 | 2014 | 551 | 0.020 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2010 | 131 | 0.020 |
Why?
| Angiotensin II | 1 | 2010 | 108 | 0.020 |
Why?
| Cardiac Pacing, Artificial | 1 | 2010 | 90 | 0.020 |
Why?
| Molecular Sequence Data | 1 | 2014 | 2933 | 0.020 |
Why?
| Blood Glucose | 1 | 2018 | 1957 | 0.020 |
Why?
| Extracellular Matrix Proteins | 1 | 2010 | 133 | 0.020 |
Why?
| Pacemaker, Artificial | 1 | 2010 | 116 | 0.020 |
Why?
| Matrix Metalloproteinase 14 | 1 | 2008 | 3 | 0.020 |
Why?
| Endothelin-1 | 1 | 2010 | 170 | 0.020 |
Why?
| Tachycardia, Ventricular | 1 | 2010 | 174 | 0.020 |
Why?
| Enzyme Activation | 1 | 2010 | 864 | 0.020 |
Why?
| Phosphorylation | 1 | 2012 | 1733 | 0.020 |
Why?
| Mice, Knockout | 1 | 2014 | 2737 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 1003 | 0.020 |
Why?
| Transforming Growth Factor beta | 1 | 2010 | 468 | 0.020 |
Why?
| Electrocardiography | 1 | 2010 | 620 | 0.020 |
Why?
| Recovery of Function | 1 | 2010 | 610 | 0.020 |
Why?
| Collagen | 1 | 2008 | 436 | 0.020 |
Why?
| Fibrosis | 1 | 2008 | 497 | 0.020 |
Why?
| Humans | 5 | 2021 | 122796 | 0.020 |
Why?
| Genotype | 1 | 2010 | 1943 | 0.020 |
Why?
| Immunohistochemistry | 1 | 2008 | 1727 | 0.010 |
Why?
| Tocopherols | 1 | 2003 | 20 | 0.010 |
Why?
| Retinoid X Receptors | 1 | 2003 | 38 | 0.010 |
Why?
| Receptors, Retinoic Acid | 1 | 2003 | 42 | 0.010 |
Why?
| Receptors, Steroid | 1 | 2003 | 54 | 0.010 |
Why?
| Tretinoin | 1 | 2003 | 119 | 0.010 |
Why?
| Mutagenesis, Site-Directed | 1 | 2003 | 368 | 0.010 |
Why?
| Paclitaxel | 1 | 2003 | 202 | 0.010 |
Why?
| Molecular Structure | 1 | 2003 | 463 | 0.010 |
Why?
| Cells, Cultured | 1 | 2010 | 4162 | 0.010 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 196 | 0.010 |
Why?
| Ligands | 1 | 2003 | 582 | 0.010 |
Why?
| Age Factors | 1 | 2008 | 3114 | 0.010 |
Why?
| Recombinant Fusion Proteins | 1 | 2003 | 661 | 0.010 |
Why?
| Antioxidants | 1 | 2003 | 581 | 0.010 |
Why?
| Protein Binding | 1 | 2003 | 2010 | 0.010 |
Why?
| DNA-Binding Proteins | 1 | 2003 | 1384 | 0.010 |
Why?
| Signal Transduction | 1 | 2008 | 4902 | 0.010 |
Why?
| Antineoplastic Agents | 1 | 2003 | 1990 | 0.010 |
Why?
|
|
Chang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|